Attached files

file filename
8-K - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES - SILICON LABORATORIES INC.a14-11093_18k.htm

Exhibit 99

 

GRAPHIC

 

SILICON LABS ANNOUNCES FIRST QUARTER 2014 RESULTS

– Company Sees Growing Momentum in the Internet of Things –

 

AUSTIN, Texas — April 29, 2014 — Silicon Labs (NASDAQ: SLAB), a leader in high-performance, analog-intensive, mixed-signal integrated circuits (ICs), today reported financial results for its first quarter ended March 29, 2014. Revenue in the first quarter was at the top end of guidance at $145.7 million, compared with $146.2 million reported in the fourth quarter. Additionally, the company reported excellent performance on its balance sheet with strong cash flows and effective working capital management.

 

Q1 Financial Highlights

 

On a GAAP basis:

 

·                  Gross margin was 59.8 percent

·                  R&D expenses were $42.5 million

·                  SG&A expenses were $34.6 million

·                  Operating income as a percentage of revenue was 6.9 percent

·                  Diluted earnings per share were $0.18

 

On a non-GAAP basis (results exclude the impact of stock compensation, amortization from acquired intangible assets and certain other items as set forth in the reconciliation tables below):

 

·                  Gross margin was 60.2 percent

·                  R&D expenses were $35.0 million

·                  SG&A expenses were $28.5 million

·                  Operating income was 16.6 percent

·                  Diluted earnings per share were $0.42

 

Business Highlights

 

·                  Broad-based revenue was $72.3 million, essentially flat sequentially, as expected.

·                  Broadcast exceeded expectations with revenue of $50.7 million, including record revenue in video.

·                  Access revenue decreased slightly, as expected, to $22.7 million.

 



 

Product Highlights

 

·                  Introduced a new version of the Simplicity Studio™ development ecosystem supporting Silicon Labs’ MCU products in a single, unified platform, making the embedded design process easier, faster and more efficient.

 

·                  Announced the expansion of Silicon Labs’ Ember® ZigBee® portfolio with the introduction of a new ARM®-based system-on-a-chip family that reduces the cost and complexity of deploying ZigBee solutions in smart metering and home automation applications.

 

·                  Launched the industry’s first single-chip digital ultraviolet (UV) index sensor ICs designed to track UV sun exposure, heart rate and blood oxygen levels for wearable products such as smart watches and health and fitness trackers.

 

·                  Acquired the full product portfolio and intellectual property of Silicon Valley-based Touchstone Semiconductor, an early-stage technology company and provider of low-power analog IC products targeting Internet of Things applications.

 

Business Outlook

 

The company expects revenue in the second quarter to be in the range of $147 million to $151 million.  Second quarter diluted earnings per share are expected to be between $0.15 and $0.19 on a GAAP basis and between $0.43 and $0.47 on a non-GAAP basis. Both GAAP and non-GAAP estimates include an estimated $0.03 per share effect from litigation costs.

 

“We continue to strengthen our position as a leading supplier of silicon solutions for the Internet of Things,” said Tyson Tuttle, CEO of Silicon Labs. “We expect this momentum to drive record Broad-based revenue in the second quarter.”

 

Webcast and Conference Call

 

A conference call discussing the quarterly results will follow this press release at 7:30 a.m. Central time. An audio webcast will be available simultaneously on Silicon Labs’ website under Investor Relations (www.silabs.com). A replay will be available after the call at the same website listed above or by calling 1 (855) 859-2056 or (404) 537-3406 (international) and by entering 39717388. The replay will be available through May 29.

 

About Silicon Labs

 

Silicon Labs is an industry leader in the innovation of high-performance, analog-intensive, mixed-signal ICs. Developed by a world-class engineering team with unsurpassed expertise in mixed-signal design, Silicon Labs’ diverse portfolio of patented semiconductor solutions offers customers significant advantages in performance, size and power consumption. For more information about Silicon Labs, please visit www.silabs.com.

 

Forward-Looking Statements

 

This press release contains forward-looking statements based on Silicon Labs’ current expectations. The words “believe,” “estimate,” “expect,” “intend,” “anticipate,” “plan,” “project,” “will” and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements.

 



 

These forward-looking statements reflect the current views and assumptions of Silicon Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; dependence on a limited number of products and customers; intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing our distributors, manufacturers and subcontractors; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with our accounts receivable; dependence on key personnel; stock price volatility; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs’ business and results of operations to risks of natural disasters, epidemics, war and political unrest; debt-related risks; capital-raising risks; the competitive and cyclical nature of the semiconductor industry; average selling prices of products may decrease significantly and rapidly; information technology risks; conflict mineral risks and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.

 

Note to editors: Silicon Laboratories, Silicon Labs, the Silicon Labs logo, Simplicity Studio and Ember are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

 

CONTACT: Deborah Stapleton, +1 650.470.4200, Deborah.Stapleton@silabs.com

 



 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Income

 (In thousands, except per share data)

(Unaudited)

 

 

 

Three Months Ended

 

 

 

March 29,
2014

 

March 30,
2013

 

Revenues

 

$

145,691

 

$

145,375

 

Cost of revenues

 

58,586

 

58,003

 

Gross margin

 

87,105

 

87,372

 

Operating expenses:

 

 

 

 

 

Research and development

 

42,485

 

37,582

 

Selling, general and administrative

 

34,611

 

29,153

 

Operating expenses

 

77,096

 

66,735

 

Operating income

 

10,009

 

20,637

 

Other income (expense):

 

 

 

 

 

Interest income

 

302

 

335

 

Interest expense

 

(798

)

(842

)

Other income (expense), net

 

67

 

(52

)

Income before income taxes

 

9,580

 

20,078

 

Provision for income taxes

 

1,470

 

44

 

 

 

 

 

 

 

Net income

 

$

8,110

 

$

20,034

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

Basic

 

$

0.19

 

$

0.47

 

Diluted

 

$

0.18

 

$

0.46

 

 

 

 

 

 

 

Weighted-average common shares outstanding:

 

 

 

 

 

Basic

 

43,081

 

42,186

 

Diluted

 

44,056

 

43,110

 

 



 

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

(In thousands, except per share data)

 

 

 

Three Months Ended
March 29, 2014

 

Non-GAAP Income
Statement Items

 

GAAP
Measure

 

GAAP
Percent of
Revenue

 

Stock
Compensation
Expense

 

Intangible
Asset
Amortization

 

Termination
Costs

 

Acquisition
Related
Items

 

Non-GAAP
Measure

 

Non-
GAAP
Percent of
Revenue

 

Revenues

 

$

145,691

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin

 

87,105

 

59.8

%

$

195

 

$

390

 

$

 

$

 

$

87,690

 

60.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

42,485

 

29.2

%

4,241

 

3,247

 

 

 

34,997

 

24.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

34,611

 

23.7

%

4,841

 

729

 

(267

)

816

 

28,492

 

19.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

10,009

 

6.9

%

9,277

 

4,366

 

(267

)

816

 

24,201

 

16.6

%

 

 

 

Three Months Ended
March 29, 2014

 

Non-GAAP Diluted
Earnings Per Share

 

GAAP
Measure

 

Stock
Compensation
Expense

 

Intangible
Asset
Amortization

 

Termination
Costs

 

Acquisition
Related
Items

 

Release of
Unrecognized
Tax Benefits

 

Non-
GAAP
Measure

 

Net income

 

$

8,110

 

$

7,966

 

$

3,019

 

$

(199

)

$

816

 

$

(1,292

)

$

18,420

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted shares outstanding

 

44,056

 

 

 

 

 

 

44,056

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share

 

$

0.18

 

 

 

 

 

 

 

 

 

 

 

$

0.42

 

 

Unaudited Forward-Looking Statements Regarding Business Outlook

(In thousands, except per share information)

 

 

 

Three Months Ending
June 28, 2014

 

Business Outlook

 

High

 

Low

 

Estimated GAAP diluted earnings per share

 

$

0.19

 

$

0.15

 

 

 

 

 

 

 

Estimated non-GAAP charges

 

0.28

 

0.28

 

 

 

 

 

 

 

Estimated non-GAAP diluted earnings per share

 

$

0.47

 

$

0.43

 

 



 

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

 

 

 

March 29,
 2014

 

December 28,
 2013

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

128,323

 

$

95,800

 

Short-term investments

 

194,765

 

179,593

 

Accounts receivable, net of allowances for doubtful accounts of $767 at March 29, 2014 and $797 at December 28, 2013

 

64,672

 

72,124

 

Inventories

 

44,334

 

45,271

 

Deferred income taxes

 

15,203

 

18,878

 

Prepaid expenses and other current assets

 

40,214

 

47,651

 

Total current assets

 

487,511

 

459,317

 

Long-term investments

 

10,997

 

10,632

 

Property and equipment, net

 

130,829

 

132,445

 

Goodwill

 

228,781

 

228,781

 

Other intangible assets, net

 

128,453

 

131,593

 

Other assets, net

 

23,482

 

28,382

 

Total assets

 

$

1,010,053

 

$

991,150

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

22,707

 

$

22,126

 

Current portion of long-term debt

 

8,750

 

7,500

 

Accrued expenses

 

67,745

 

45,975

 

Deferred income on shipments to distributors

 

32,589

 

30,853

 

Income taxes

 

1,330

 

2,693

 

Total current liabilities

 

133,121

 

109,147

 

Long-term debt

 

85,000

 

87,500

 

Other non-current liabilities

 

30,737

 

55,941

 

Total liabilities

 

248,858

 

252,588

 

Commitments and contingencies

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock — $0.0001 par value; 10,000 shares authorized; no shares issued and outstanding

 

 

 

Common stock — $0.0001 par value; 250,000 shares authorized; 43,433 and 42,779 shares issued and outstanding at March 29, 2014 and December 28, 2013, respectively

 

4

 

4

 

Additional paid-in capital

 

62,883

 

48,630

 

Retained earnings

 

698,722

 

690,612

 

Accumulated other comprehensive loss

 

(414

)

(684

)

Total stockholders’ equity

 

761,195

 

738,562

 

Total liabilities and stockholders’ equity

 

$

1,010,053

 

$

991,150

 

 



 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

 

 

Three Months Ended

 

 

 

March 29,
 2014

 

March 30,
 2013

 

Operating Activities

 

 

 

 

 

Net income

 

$

8,110

 

$

20,034

 

Adjustments to reconcile net income to cash provided by operating activities:

 

 

 

 

 

Depreciation of property and equipment

 

3,290

 

3,297

 

Amortization of other intangible assets and other assets

 

4,491

 

2,840

 

Stock-based compensation expense

 

9,277

 

6,260

 

Income tax benefit (shortfall) from stock-based awards

 

45

 

(363

)

Excess income tax benefit from stock-based awards

 

(235

)

(217

)

Deferred income taxes

 

6,784

 

7,521

 

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

7,452

 

5,256

 

Inventories

 

1,083

 

(7,350

)

Prepaid expenses and other assets

 

14,266

 

4,620

 

Accounts payable

 

1,195

 

2,356

 

Accrued expenses

 

(2,218

)

(4,330

)

Deferred income on shipments to distributors

 

1,736

 

(598

)

Income taxes

 

(8,324

)

(9,818

)

Net cash provided by operating activities

 

46,952

 

29,508

 

 

 

 

 

 

 

Investing Activities

 

 

 

 

 

Purchases of available-for-sale investments

 

(43,366

)

(78,851

)

Proceeds from sales and maturities of available-for-sale investments

 

28,242

 

25,674

 

Purchases of property and equipment

 

(1,673

)

(3,898

)

Purchases of other assets

 

(2,113

)

(1,228

)

Net cash used in investing activities

 

(18,910

)

(58,303

)

 

 

 

 

 

 

Financing Activities

 

 

 

 

 

Proceeds from issuance of common stock, net of shares withheld for taxes

 

5,496

 

4,915

 

Excess income tax benefit from stock-based awards

 

235

 

217

 

Payments on debt

 

(1,250

)

(2,500

)

Net cash provided by financing activities

 

4,481

 

2,632

 

 

 

 

 

 

 

Increase (decrease) in cash and cash equivalents

 

32,523

 

(26,163

)

Cash and cash equivalents at beginning of period

 

95,800

 

105,426

 

Cash and cash equivalents at end of period

 

$

128,323

 

$

79,263

 

 

###